EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications

Janice J N Li iD, Geoffrey Liu, Benjamin H Lok iD

Genes · 2024

DOI: 10.3390/genes15091160 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Janice J N Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Princess Margaret Cancer Research Tower, 101 College Street, Ro…. Hauptthemen laut MEDLINE: 5-Methylcytosine, DNA Methylation, Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Research Institute, Canada Foundation for Innovation, Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the era of precision oncology, identifying abnormal genetic and epigenetic alterations has transformed the way cancer is diagnosed, managed, and treated. 5-hydroxymethylcytosine (5hmC) is an emerging epigenetic modification formed through the oxidation of 5-methylcytosine (5mC) by ten-eleven translocase (TET) enzymes. DNA hydroxymethylation exhibits tissue- and cancer-specific patterns and is essential in DNA demethylation and gene regulation. Recent advancements in 5hmC detection methods and the discovery of 5hmC in cell-free DNA (cfDNA) have highlighted the potential for cell-free 5hmC as a cancer biomarker. This review explores the current and emerging techniques and applications of DNA hydroxymethylation in cancer, particularly in the context of cfDNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5-MethylcytosineDNA MethylationNeoplasmsCell-Free Nucleic AcidsBiomarkers, TumorHumansEpigenesis, Genetic

Stichwörter der Autor:innen

5-hydroxymethylcytosineDNA hydroxymethylationcancer biomarkercell-free DNAepigeneticsliquid biopsy

Substanzen

5-Methylcytosine5-hydroxymethylcytosineCell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Princess Margaret Cancer Research Tower, 101 College Street, Room 9-309, Toronto, ON M5G 1L7, Canada.
  • Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Room 2374, Toronto, ON M5S 1A8, Canada.
  • Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2C4, Canada.
  • Radiation Medicine Program, Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2C4, Canada.

ORCID-Profile: Janice J N Li, Benjamin H Lok

Förderung

  • Terry Fox Research Institute
  • Canada Foundation for Innovation
  • Cancer Research Society
  • Canadian Institutes of Health Research
  • National Institute of Health/National Cancer Institute
  • Clinical and Translational Science Center at Weill Cornell Medical Center
  • MSKCC
  • M. Qasim Choksi Chair in Lung Cancer Translational Research

Zitieren

APA

Li, J. J. N., Liu, G., & Lok, B. H. (2024). Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications. Genes. https://doi.org/10.3390/genes15091160

Vancouver

Li JJN, Liu G, Lok BH. Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications. Genes. 2024. doi:10.3390/genes15091160

BibTeX
@article{Li2024,
  author = {Li, Janice J N and Liu, Geoffrey and Lok, Benjamin H},
  title = {Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15091160}
}
Kostenlos starten →